Showing results (811-820 of 1,296) with videos related to
Sort By:
Pageof 130
Nature Reviews. Drug Discovery|April 11, 2019
Therapeutic targeting of trained immunityWillem J M Mulder, Jordi Ochando, Leo A B Joosten, et al.Nature Reviews. Drug Discovery|July 8, 2017
Opportunities and challenges in phenotypic drug discovery: an industry perspectiveJohn G Moffat, Fabien Vincent, Jonathan A Lee, et al.Nature Reviews. Drug Discovery|May 11, 2019
Aminoacyl-tRNA synthetases as therapeutic targetsNam Hoon Kwon, Paul L Fox, Sunghoon KimNature Reviews. Drug Discovery|December 19, 2019
Advances in oral peptide therapeuticsDaniel J DruckerNature Reviews. Drug Discovery|June 1, 2022
Drugging the efferocytosis process: concepts and opportunitiesParul Mehrotra, Kodi S RavichandranNature Reviews. Drug Discovery|May 31, 2022
Phenotypic drug discovery: recent successes, lessons learned and new directionsFabien Vincent, Arsenio Nueda, Jonathan Lee, et al.Nature Reviews. Drug Discovery|March 17, 2018
Kinase inhibitors: the road aheadFleur M Ferguson, Nathanael S GrayNature Reviews. Drug Discovery|June 6, 2022
Thinking outside the box: non-canonical targets in multiple sclerosisLaura Bierhansl, Hans-Peter Hartung, Orhan Aktas, et al.Nature Reviews. Drug Discovery|June 14, 2022
Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunitiesTae Kon Kim, Esten N Vandsemb, Roy S Herbst, et al.Nature Reviews. Drug Discovery|June 12, 2021
Zebrafish disease models in drug discovery: from preclinical modelling to clinical trialsE Elizabeth Patton, Leonard I Zon, David M LangenauPageof 130